The GAO Report about the FDA’s Inspection Workforce: the Implications for Federal Government Contractors in Clinical Research
FDA Office Manager FDA Office Manager

The GAO Report about the FDA’s Inspection Workforce: the Implications for Federal Government Contractors in Clinical Research

This blog post summarizes the GAO report on FDA's challenges in inspecting clinical research, emphasizing its implications for federal contractors in drug development. It discusses the decline in inspections, alternative oversight tools, and workforce recruitment issues, offering insights for navigating regulatory uncertainties and ensuring compliance.

Read More